Treatment of influenza
AssigneeKyorin Pharmaceutical Co., Ltd.
InventorsMisako NAKAZAWA, Shin-etsu Kadowaki, Yoshiji Fujita, Masato Miyake, Takanori Ueda, Tomohiro Yoshikawa
Life of this patent
Estimating the term…
Abstract
The present invention provides a double-stranded RNA which inhibits replication of influenza B viruses by RNA interference, in which the double-stranded RNA comprises an RNA having 19 to 25 nucleotides homologous with a part of an mRNA transcribed from a genomic RNA of the influenza B viruses and an antisense RNA thereof.
Claims4
A method for treatment of an infectious disease caused by influenza comprising administering to a patient in need thereof at least one kind of a double-stranded RNA having an RNA and an antisense RNA thereof, wherein the RNA is selected from the group consisting of nucleotide sequences as set forth in SEQ ID NOs:
- 1, 2, 3, 6, 7, 8, 9, 10 and 11 in which 1 to 3 nucleotide(s) is/are substituted as an active ingredient.
Dependencies are inferred from the claim text.